Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

MPW vs NHI: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

MPW Wins Head-to-Head Institutional Verdict (5–1 across 6 Pillars · 5–5 Matrix Metrics)

MPW Overall Winner 6-Pillar Tally: MPW 5 – 1 NHI Matrix Metrics: MPW 5 – 5 NHI

As of Nov 16, 2026, Medical Properties Trust, Inc. (MPW) is the stronger overall head-to-head candidate over National Health Investors (NHI) in the Tradestie Institutional Equity Comparison Engine, winning 5–5 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). MPW carries a Unified Composite Score of 52.6/100 (HOLD) at $5.02 (6.7x Forward P/E, 58.2% operating margin), whereas NHI carries 31.7/100 (SELL) at $61.97 (18.2x Forward P/E, 42.5% operating margin).

  • Growth vs. Quality Trade-Off: MPW earns the overall head-to-head edge with a stronger Unified Composite Score (52.6/100 HOLD vs. NHI 31.7/100 SELL) and 0.14β · 26% Vol risk profile, whereas NHI leads top-line expansion (+26.3% YoY revenue growth, 4.76x PEG, and 1 of 6 institutional pillars) for higher-beta growth mandates.
  • Technical & Structure Timing Caution: MPW trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 42.4); meanwhile NHI is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 32.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About MPW vs NHI
MPW NYSE Head-to-Head Winner
Medical Properties Trust, Inc.
Real Estate Investment Trusts
$5.02
-0.59% 1D
Market Cap $3.0B
TTM Revenue $1.01B
Forward P/E 6.7x
Beta / 30D Vol 0.14β · 26% Vol
Unified Composite Score
52.6 / 100 HOLD
Tech 25.0 Fund 45.0 Flow 67.0 Mom 47.3
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 42
RSI-14: 42.4 · SMA20: $5.18 · SMA50: $5.24
NHI NYSE
National Health Investors
Real Estate Investment Trusts
$61.97
-1.56% 1D
Market Cap $3.2B
TTM Revenue $459M
Forward P/E 18.2x
Beta / 30D Vol -0.21β · 34% Vol
Unified Composite Score
31.7 / 100 SELL
Tech 12.0 Fund 35.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -3.0%), weak momentum, RSI 32
RSI-14: 32.2 · SMA20: $67.24 · SMA50: $67.11

6-Pillar Scorecard Institutional Category Breakdown (MPW 5 – 1 NHI)

Columns: Metric · MPW · NHI
1. Valuation Multiples MPW
Forward P/E 6.7x 18.2x
Trailing P/E 6.7x 4.6x
PEG Ratio 1.93x 4.76x
EV / Revenue 3.0x 6.9x
2. Growth & Scale NHI
Revenue Growth (YoY) +9.9% +26.3%
Earnings Growth (YoY) -48.6% N/A
TTM Revenue (USD) $1.01B $459M
Market Cap $3.0B $3.2B
3. Profitability & Quality MPW
Gross Margin 96.4% 71.2%
Operating Margin 58.2% 42.5%
Net Profit Margin -70.1% 151.8%
Return on Equity (ROE) -14.0% 38.6%
4. Balance Sheet & Cash Flow MPW
Cash Generation (TTM) $823M EBITDA $292M EBITDA
Cash Flow Margin 81.6% EBITDA Mgn 63.5% EBITDA Mgn
Net Cash / Leverage $7.75 Book/Sh · -14.0% ROE $42.56 Book/Sh · 38.6% ROE
Dividend Yield 6.34% 5.60%
5. Options & Positioning MPW
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile 24.3% (25th %ile) 19.1% (2nd %ile)
Put/Call OI Skew 0.79x (Call-Skewed) N/A
OBV Trend / Tech Phase NEUTRAL · Neutral NEUTRAL · Markdown
6. R&D & Supply-Chain Moat MPW
OpEx & R&D Intensity 38.2% of Rev ($385M) 28.7% of Rev ($132M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat High-Margin Pricing Power Moat High-Margin Pricing Power Moat
Supply-Chain Role REIT - Healthcare Facilities Operator REIT - Healthcare Facilities Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: MPW (5) vs NHI (5)
Institutional Metric MPW NHI Criterion Row Edge
Market Capitalization
Scale
$3.0B $3.2B Larger Scale NHI
Trailing P/E Ratio
Valuation
6.7x 4.6x Lower Multiple NHI
Forward P/E Ratio
Valuation
6.7x 18.2x Lower Multiple MPW
Revenue Growth (YoY)
Growth
+9.9% +26.3% Higher Growth NHI
Operating Margin (TTM)
Profitability
58.2% 42.5% Higher Margin MPW
Net Profit Margin
Profitability
-70.1% 151.8% Higher Margin NHI
Return on Equity (ROE)
Capital Efficiency
-14.0% 38.6% Higher ROE NHI
52-Week Range Position
Momentum
45% ($4–$6) 1% ($62–$91) Stronger Trend MPW
Beta / 30D Volatility
Risk Regime
0.14β · 26% Vol -0.21β · 34% Vol Lower Realized Risk MPW
Unified Institutional Score
Composite Signal
52.6 / 100 (HOLD) 31.7 / 100 (SELL) Higher Composite MPW
Trailing 12M Revenue (USD)
Operating Scale
$1.01B $459M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
96.4% 71.2% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
1.93x PEG · 3.0x EV/Rev 4.76x PEG · 6.9x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$823M EBITDA ($7.75 Book/Sh · -14.0% ROE) $292M EBITDA ($42.56 Book/Sh · 38.6% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon NHI +6.64 pp
MPW: -0.79% · NHI: +5.85%
3M Horizon NHI +6.06 pp
MPW: +0.8% · NHI: +6.86%
6M Horizon NHI +6.06 pp
MPW: +0.8% · NHI: +6.86%
1Y Horizon NHI +6.06 pp
MPW: +0.8% · NHI: +6.86%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on MPW vs NHI. Trailing 12-month operating profitability (MPW 58.2% vs NHI 42.5%) and valuation multiples (MPW 6.7x vs NHI 18.2x Forward P/E) are benchmarked directly in Pillar 4 below.

MPW ADR TTM Benchmark FX-Normalized USD
TTM Revenue$1.01B
Gross Margin96.4%
Op. Margin58.2%
ROE / Fwd P/E-14.0% · 6.7x
NHI ADR TTM Benchmark FX-Normalized USD
TTM Revenue$459M
Gross Margin71.2%
Op. Margin42.5%
ROE / Fwd P/E38.6% · 18.2x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
MPW UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 24.3%
IV Percentile 25th %ile
Put/Call OI Skew 0.79x (Call-Skewed)
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact MPW Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
NHI UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 19.1%
IV Percentile 2nd %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact NHI Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
MPW Moat Profile High-Margin Pricing Power Moat
REIT - Healthcare Facilities Operator
Competes within the REIT - Healthcare Facilities value chain with $3.0B market capitalization and 58.2% operating margin.
OpEx & R&D Reinvestment 38.2% of Rev ($385M)
90D Engineering Disclosures 0 Published
NHI Moat Profile High-Margin Pricing Power Moat
REIT - Healthcare Facilities Operator
Competes within the REIT - Healthcare Facilities value chain with $3.2B market capitalization and 42.5% operating margin.
OpEx & R&D Reinvestment 28.7% of Rev ($132M)
90D Engineering Disclosures 0 Published

Investor FAQ MPW vs NHI Key Questions & Quantitative Answers

As of Nov 16, 2026, Medical Properties Trust, Inc. (MPW) is the stronger overall head-to-head candidate over National Health Investors (NHI) in the Tradestie Institutional Equity Comparison Engine, winning 5–5 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). MPW carries a Unified Composite Score of 52.6/100 (HOLD) at $5.02 (6.7x Forward P/E, 58.2% operating margin), whereas NHI carries 31.7/100 (SELL) at $61.97 (18.2x Forward P/E, 42.5% operating margin). Growth vs. Quality Trade-Off: MPW earns the overall head-to-head edge with a stronger Unified Composite Score (52.6/100 HOLD vs. NHI 31.7/100 SELL) and 0.14β · 26% Vol risk profile, whereas NHI leads top-line expansion (+26.3% YoY revenue growth, 4.76x PEG, and 1 of 6 institutional pillars) for higher-beta growth mandates. Technical & Structure Timing Caution: MPW trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 42.4); meanwhile NHI is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 32.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

NHI leads the Growth & Scale pillar: MPW posts +9.9% YoY revenue growth and -48.6% YoY earnings growth on $1.01B TTM revenue (96.4% gross margin, 58.2% operating margin), compared with NHI at +26.3% YoY revenue growth and N/A YoY earnings growth on $459M TTM revenue (71.2% gross margin, 42.5% operating margin). On trailing 12-month operating scale, MPW generates $1.01B in USD-normalized revenue versus $459M for NHI. In operating R&D and SG&A reinvestment, MPW deploys 38.2% of Rev ($385M) (0 90-day corporate R&D disclosures) versus 28.7% of Rev ($132M) (0 disclosures) for NHI.

MPW screens cheaper on headline valuation multiples. MPW trades at 6.7x Forward P/E, 6.7x Trailing P/E, 1.93x PEG, and 3.0x EV/Revenue (81.6% EBITDA margin), whereas NHI trades at 18.2x Forward P/E, 4.6x Trailing P/E, 4.76x PEG, and 6.9x EV/Revenue (63.5% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against MPW (-14.0% ROE) versus NHI (38.6% ROE) capital efficiency.

In options market volatility and institutional positioning, MPW carries 24.3% implied volatility (25th %ile, Balanced (25th–60th %ile)), a 0.79x (Call-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.14β · 26% Vol realized risk). By comparison, NHI carries 19.1% implied volatility (2nd %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-0.21β · 34% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.